Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager

Moberg Pharma AB (publ)

STO:MOB

Watchlist

Dividends

Price: 18.11 SEK -3.21%

Market Cap: 845.6m SEK

Have any thoughts about
Moberg Pharma AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 18.11 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MOB Alert

Moberg Pharma AB (publ)

18.11

-0.60 (-3.21%)

52 Week Range	9.645 38.92
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Moberg Pharma AB (publ)

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Moberg Pharma AB (publ).

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Has there been any significant insider trading activity
in Moberg Pharma AB (publ) recently?

Summarize the latest earnings call
of Moberg Pharma AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Moberg Pharma AB (publ).

Provide P/S
for Moberg Pharma AB (publ).

Provide P/E
for Moberg Pharma AB (publ).

Provide P/OCF
for Moberg Pharma AB (publ).

Provide P/FCFE
for Moberg Pharma AB (publ).

Provide P/B
for Moberg Pharma AB (publ).

Provide EV/S
for Moberg Pharma AB (publ).

Provide EV/GP
for Moberg Pharma AB (publ).

Provide EV/EBITDA
for Moberg Pharma AB (publ).

Provide EV/EBIT
for Moberg Pharma AB (publ).

Provide EV/OCF
for Moberg Pharma AB (publ).

Provide EV/FCFF
for Moberg Pharma AB (publ).

Provide EV/IC
for Moberg Pharma AB (publ).

Show me price targets
for Moberg Pharma AB (publ) made by professional analysts.

What are the Revenue projections
for Moberg Pharma AB (publ)?

How accurate were the past Revenue estimates
for Moberg Pharma AB (publ)?

What are the Net Income projections
for Moberg Pharma AB (publ)?

How accurate were the past Net Income estimates
for Moberg Pharma AB (publ)?

What are the EPS projections
for Moberg Pharma AB (publ)?

How accurate were the past EPS estimates
for Moberg Pharma AB (publ)?

What are the EBIT projections
for Moberg Pharma AB (publ)?

How accurate were the past EBIT estimates
for Moberg Pharma AB (publ)?

Compare the revenue forecasts
for Moberg Pharma AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Moberg Pharma AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Moberg Pharma AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Moberg Pharma AB (publ) compared to its peers.

Compare the P/E ratios
of Moberg Pharma AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Moberg Pharma AB (publ) with its peers.

Analyze the financial leverage
of Moberg Pharma AB (publ) compared to its main competitors.

Show all profitability ratios
for Moberg Pharma AB (publ).

Provide ROE
for Moberg Pharma AB (publ).

Provide ROA
for Moberg Pharma AB (publ).

Provide ROIC
for Moberg Pharma AB (publ).

Provide ROCE
for Moberg Pharma AB (publ).

Provide Gross Margin
for Moberg Pharma AB (publ).

Provide Operating Margin
for Moberg Pharma AB (publ).

Provide Net Margin
for Moberg Pharma AB (publ).

Provide FCF Margin
for Moberg Pharma AB (publ).

Show all solvency ratios
for Moberg Pharma AB (publ).

Provide D/E Ratio
for Moberg Pharma AB (publ).

Provide D/A Ratio
for Moberg Pharma AB (publ).

Provide Interest Coverage Ratio
for Moberg Pharma AB (publ).

Provide Altman Z-Score Ratio
for Moberg Pharma AB (publ).

Provide Quick Ratio
for Moberg Pharma AB (publ).

Provide Current Ratio
for Moberg Pharma AB (publ).

Provide Cash Ratio
for Moberg Pharma AB (publ).

What is the historical Revenue growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the historical Net Income growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the current Free Cash Flow
of Moberg Pharma AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Moberg Pharma AB (publ).

Section:

Wall Street
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Wall Street analysts forecast MOB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOB is 19.38 SEK with a low forecast of 19.19 SEK and a high forecast of 19.95 SEK.

Lowest

Price Target

19.19 SEK

6% Upside

Average

Price Target

19.38 SEK

7% Upside

Highest

Price Target

19.95 SEK

10% Upside

Moberg Pharma AB (publ) Competitors:
Price Targets

600332

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

5% Downside

002399

Shenzhen Hepalink Pharmaceutical Group Co Ltd

31% Downside

HIKAL

Hikal Ltd

14% Upside

300765

CSPC Innovation Pharmaceutical Co Ltd

52% Upside

600332

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

5% Downside

002399

Shenzhen Hepalink Pharmaceutical Group Co Ltd

31% Downside

HIKAL

Hikal Ltd

14% Upside

300765

CSPC Innovation Pharmaceutical Co Ltd

52% Upside

4151

Kyowa Kirin Co Ltd

37% Upside

CONCORDBIO

Concord Biotech Ltd

2% Downside

214370

Caregen Co Ltd

41% Downside

Revenue
Forecast

Revenue Estimate
Moberg Pharma AB (publ)

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Moberg Pharma AB (publ)

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Moberg Pharma AB (publ)

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is MOB's stock price target?

Price Target
19.38 SEK

According to Wall Street analysts, the average 1-year price target for MOB is 19.38 SEK with a low forecast of 19.19 SEK and a high forecast of 19.95 SEK.

Moberg Pharma AB (publ)
STO:MOB

Wall Street
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Revenue
Forecast

Revenue Estimate
Moberg Pharma AB (publ)

Operating Income
Forecast

Operating Income Estimate
Moberg Pharma AB (publ)

Net Income
Forecast

Net Income Estimate
Moberg Pharma AB (publ)

See Also

What is MOB's stock price target?

Price Target
19.38 SEK

Company

Help

Tools

Stocks

Moberg Pharma AB (publ) STO:MOB

Wall Street Price Targets

MOB Price Targets Summary Moberg Pharma AB (publ)

Revenue Forecast

Revenue Estimate Moberg Pharma AB (publ)

Operating Income Forecast

Operating Income Estimate Moberg Pharma AB (publ)

Net Income Forecast

Net Income Estimate Moberg Pharma AB (publ)

See Also

What is MOB's stock price target? Price Target 19.38 SEK

Company

Help

Tools

Stocks

Moberg Pharma AB (publ)
STO:MOB

Wall Street
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Revenue
Forecast

Revenue Estimate
Moberg Pharma AB (publ)

Operating Income
Forecast

Operating Income Estimate
Moberg Pharma AB (publ)

Net Income
Forecast

Net Income Estimate
Moberg Pharma AB (publ)

What is MOB's stock price target?

Price Target
19.38 SEK